"Insulin Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Descriptor ID |
D007333
|
| MeSH Number(s) |
C18.452.394.968.500 G07.690.773.984.617
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Insulin Resistance".
Below are MeSH descriptors whose meaning is more specific than "Insulin Resistance".
This graph shows the total number of publications written about "Insulin Resistance" by people in this website by year, and whether "Insulin Resistance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 2 | 5 |
| 1996 | 1 | 3 | 4 |
| 1997 | 3 | 2 | 5 |
| 1998 | 2 | 1 | 3 |
| 1999 | 3 | 1 | 4 |
| 2000 | 9 | 3 | 12 |
| 2001 | 4 | 0 | 4 |
| 2002 | 3 | 6 | 9 |
| 2003 | 2 | 4 | 6 |
| 2004 | 3 | 3 | 6 |
| 2005 | 5 | 9 | 14 |
| 2006 | 2 | 6 | 8 |
| 2007 | 3 | 3 | 6 |
| 2008 | 3 | 5 | 8 |
| 2009 | 6 | 6 | 12 |
| 2010 | 2 | 5 | 7 |
| 2011 | 5 | 3 | 8 |
| 2012 | 8 | 10 | 18 |
| 2013 | 6 | 8 | 14 |
| 2014 | 8 | 10 | 18 |
| 2015 | 6 | 12 | 18 |
| 2016 | 6 | 5 | 11 |
| 2017 | 2 | 8 | 10 |
| 2018 | 6 | 6 | 12 |
| 2019 | 5 | 10 | 15 |
| 2020 | 4 | 2 | 6 |
| 2021 | 10 | 3 | 13 |
| 2022 | 16 | 0 | 16 |
| 2023 | 2 | 0 | 2 |
| 2024 | 2 | 3 | 5 |
| 2025 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin Resistance" by people in Profiles.
-
GLP-1R/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic ß-cell function in obese male mice. Nat Commun. 2025 May 21; 16(1):4714.
-
Semaglutide and bariatric surgery induce distinct changes in the composition of mouse white adipose tissue. Mol Metab. 2025 May; 95:102126.
-
Metabolic dysfunction-associated steatotic liver disease in adults. Nat Rev Dis Primers. 2025 Mar 06; 11(1):14.
-
Divergent roles of m6A in orchestrating brown and white adipocyte transcriptomes and systemic metabolism. Nat Commun. 2025 Jan 09; 16(1):533.
-
m6A mRNA methylation in brown fat regulates systemic insulin sensitivity via an inter-organ prostaglandin signaling axis independent of UCP1. Cell Metab. 2024 Oct 01; 36(10):2207-2227.e9.
-
Genetic Background Strongly Influences the Impact of Carrying the Thr92Ala-DIO2 Polymorphism in the Male Mouse. Endocrinology. 2024 May 27; 165(7).
-
Donor and recipient genetics: Implications for the development of posttransplant diabetes mellitus. Am J Transplant. 2024 Oct; 24(10):1794-1802.
-
SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes. J Clin Invest. 2024 May 07; 134(12).
-
Werner Syndrome and Diabetes: Opportunities for Precision Medicine. Diabetes Care. 2024 May 01; 47(5):785-786.
-
Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance. J Hepatol. 2023 12; 79(6):1524-1541.